Global Tinea Corporis Drugs Market Research Report 2023

Report ID: 1891883 | Published Date: Oct 2024 | No. of Page: 84 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Tinea Corporis Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Antifungals
        1.2.3 Steroids
        1.2.4 Anti-Infective Combinations
    1.3 Market by Application
        1.3.1 Global Tinea Corporis Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Tinea Corporis Drugs Market Perspective (2017-2028)
    2.2 Tinea Corporis Drugs Growth Trends by Region
        2.2.1 Tinea Corporis Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Tinea Corporis Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Tinea Corporis Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Tinea Corporis Drugs Market Dynamics
        2.3.1 Tinea Corporis Drugs Industry Trends
        2.3.2 Tinea Corporis Drugs Market Drivers
        2.3.3 Tinea Corporis Drugs Market Challenges
        2.3.4 Tinea Corporis Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Tinea Corporis Drugs Players by Revenue
        3.1.1 Global Top Tinea Corporis Drugs Players by Revenue (2017-2022)
        3.1.2 Global Tinea Corporis Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Tinea Corporis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Tinea Corporis Drugs Revenue
    3.4 Global Tinea Corporis Drugs Market Concentration Ratio
        3.4.1 Global Tinea Corporis Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Tinea Corporis Drugs Revenue in 2021
    3.5 Tinea Corporis Drugs Key Players Head office and Area Served
    3.6 Key Players Tinea Corporis Drugs Product Solution and Service
    3.7 Date of Enter into Tinea Corporis Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Tinea Corporis Drugs Breakdown Data by Type
    4.1 Global Tinea Corporis Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Tinea Corporis Drugs Forecasted Market Size by Type (2023-2028)
5 Tinea Corporis Drugs Breakdown Data by Application
    5.1 Global Tinea Corporis Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Tinea Corporis Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Tinea Corporis Drugs Market Size (2017-2028)
    6.2 North America Tinea Corporis Drugs Market Size by Country (2017-2022)
    6.3 North America Tinea Corporis Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Tinea Corporis Drugs Market Size (2017-2028)
    7.2 Europe Tinea Corporis Drugs Market Size by Country (2017-2022)
    7.3 Europe Tinea Corporis Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Tinea Corporis Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Tinea Corporis Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Tinea Corporis Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Tinea Corporis Drugs Market Size (2017-2028)
    9.2 Latin America Tinea Corporis Drugs Market Size by Country (2017-2022)
    9.3 Latin America Tinea Corporis Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Tinea Corporis Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Tinea Corporis Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Tinea Corporis Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Sun Pharmaceutical
        11.1.1 Sun Pharmaceutical Company Detail
        11.1.2 Sun Pharmaceutical Business Overview
        11.1.3 Sun Pharmaceutical Tinea Corporis Drugs Introduction
        11.1.4 Sun Pharmaceutical Revenue in Tinea Corporis Drugs Business (2017-2022)
        11.1.5 Sun Pharmaceutical Recent Development
    11.2 Teva
        11.2.1 Teva Company Detail
        11.2.2 Teva Business Overview
        11.2.3 Teva Tinea Corporis Drugs Introduction
        11.2.4 Teva Revenue in Tinea Corporis Drugs Business (2017-2022)
        11.2.5 Teva Recent Development
    11.3 Glenmark
        11.3.1 Glenmark Company Detail
        11.3.2 Glenmark Business Overview
        11.3.3 Glenmark Tinea Corporis Drugs Introduction
        11.3.4 Glenmark Revenue in Tinea Corporis Drugs Business (2017-2022)
        11.3.5 Glenmark Recent Development
    11.4 Aurobindo
        11.4.1 Aurobindo Company Detail
        11.4.2 Aurobindo Business Overview
        11.4.3 Aurobindo Tinea Corporis Drugs Introduction
        11.4.4 Aurobindo Revenue in Tinea Corporis Drugs Business (2017-2022)
        11.4.5 Aurobindo Recent Development
    11.5 AvKare
        11.5.1 AvKare Company Detail
        11.5.2 AvKare Business Overview
        11.5.3 AvKare Tinea Corporis Drugs Introduction
        11.5.4 AvKare Revenue in Tinea Corporis Drugs Business (2017-2022)
        11.5.5 AvKare Recent Development
    11.6 Novartis
        11.6.1 Novartis Company Detail
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Tinea Corporis Drugs Introduction
        11.6.4 Novartis Revenue in Tinea Corporis Drugs Business (2017-2022)
        11.6.5 Novartis Recent Development
    11.7 Sebela
        11.7.1 Sebela Company Detail
        11.7.2 Sebela Business Overview
        11.7.3 Sebela Tinea Corporis Drugs Introduction
        11.7.4 Sebela Revenue in Tinea Corporis Drugs Business (2017-2022)
        11.7.5 Sebela Recent Development
    11.8 Bayer
        11.8.1 Bayer Company Detail
        11.8.2 Bayer Business Overview
        11.8.3 Bayer Tinea Corporis Drugs Introduction
        11.8.4 Bayer Revenue in Tinea Corporis Drugs Business (2017-2022)
        11.8.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Tinea Corporis Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Antifungals
    Table 3. Key Players of Steroids
    Table 4. Key Players of Anti-Infective Combinations
    Table 5. Global Tinea Corporis Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Tinea Corporis Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Tinea Corporis Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Tinea Corporis Drugs Market Share by Region (2017-2022)
    Table 9. Global Tinea Corporis Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Tinea Corporis Drugs Market Share by Region (2023-2028)
    Table 11. Tinea Corporis Drugs Market Trends
    Table 12. Tinea Corporis Drugs Market Drivers
    Table 13. Tinea Corporis Drugs Market Challenges
    Table 14. Tinea Corporis Drugs Market Restraints
    Table 15. Global Tinea Corporis Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Tinea Corporis Drugs Market Share by Players (2017-2022)
    Table 17. Global Top Tinea Corporis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tinea Corporis Drugs as of 2021)
    Table 18. Ranking of Global Top Tinea Corporis Drugs Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Tinea Corporis Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Tinea Corporis Drugs Product Solution and Service
    Table 22. Date of Enter into Tinea Corporis Drugs Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Tinea Corporis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Tinea Corporis Drugs Revenue Market Share by Type (2017-2022)
    Table 26. Global Tinea Corporis Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Tinea Corporis Drugs Revenue Market Share by Type (2023-2028)
    Table 28. Global Tinea Corporis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Tinea Corporis Drugs Revenue Market Share by Application (2017-2022)
    Table 30. Global Tinea Corporis Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Tinea Corporis Drugs Revenue Market Share by Application (2023-2028)
    Table 32. North America Tinea Corporis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Tinea Corporis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Tinea Corporis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Tinea Corporis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Tinea Corporis Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Tinea Corporis Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Tinea Corporis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Tinea Corporis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Tinea Corporis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Tinea Corporis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Sun Pharmaceutical Company Detail
    Table 43. Sun Pharmaceutical Business Overview
    Table 44. Sun Pharmaceutical Tinea Corporis Drugs Product
    Table 45. Sun Pharmaceutical Revenue in Tinea Corporis Drugs Business (2017-2022) & (US$ Million)
    Table 46. Sun Pharmaceutical Recent Development
    Table 47. Teva Company Detail
    Table 48. Teva Business Overview
    Table 49. Teva Tinea Corporis Drugs Product
    Table 50. Teva Revenue in Tinea Corporis Drugs Business (2017-2022) & (US$ Million)
    Table 51. Teva Recent Development
    Table 52. Glenmark Company Detail
    Table 53. Glenmark Business Overview
    Table 54. Glenmark Tinea Corporis Drugs Product
    Table 55. Glenmark Revenue in Tinea Corporis Drugs Business (2017-2022) & (US$ Million)
    Table 56. Glenmark Recent Development
    Table 57. Aurobindo Company Detail
    Table 58. Aurobindo Business Overview
    Table 59. Aurobindo Tinea Corporis Drugs Product
    Table 60. Aurobindo Revenue in Tinea Corporis Drugs Business (2017-2022) & (US$ Million)
    Table 61. Aurobindo Recent Development
    Table 62. AvKare Company Detail
    Table 63. AvKare Business Overview
    Table 64. AvKare Tinea Corporis Drugs Product
    Table 65. AvKare Revenue in Tinea Corporis Drugs Business (2017-2022) & (US$ Million)
    Table 66. AvKare Recent Development
    Table 67. Novartis Company Detail
    Table 68. Novartis Business Overview
    Table 69. Novartis Tinea Corporis Drugs Product
    Table 70. Novartis Revenue in Tinea Corporis Drugs Business (2017-2022) & (US$ Million)
    Table 71. Novartis Recent Development
    Table 72. Sebela Company Detail
    Table 73. Sebela Business Overview
    Table 74. Sebela Tinea Corporis Drugs Product
    Table 75. Sebela Revenue in Tinea Corporis Drugs Business (2017-2022) & (US$ Million)
    Table 76. Sebela Recent Development
    Table 77. Bayer Company Detail
    Table 78. Bayer Business Overview
    Table 79. Bayer Tinea Corporis Drugs Product
    Table 80. Bayer Revenue in Tinea Corporis Drugs Business (2017-2022) & (US$ Million)
    Table 81. Bayer Recent Development
    Table 82. Research Programs/Design for This Report
    Table 83. Key Data Information from Secondary Sources
    Table 84. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Tinea Corporis Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Antifungals Features
    Figure 3. Steroids Features
    Figure 4. Anti-Infective Combinations Features
    Figure 5. Global Tinea Corporis Drugs Market Share by Application in 2021 & 2028
    Figure 6. Hospital Pharmacies Case Studies
    Figure 7. Retail Pharmacies Case Studies
    Figure 8. Online Pharmacies Case Studies
    Figure 9. Tinea Corporis Drugs Report Years Considered
    Figure 10. Global Tinea Corporis Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Tinea Corporis Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Tinea Corporis Drugs Market Share by Region: 2021 VS 2028
    Figure 13. Global Tinea Corporis Drugs Market Share by Players in 2021
    Figure 14. Global Top Tinea Corporis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tinea Corporis Drugs as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Tinea Corporis Drugs Revenue in 2021
    Figure 16. North America Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Tinea Corporis Drugs Market Share by Country (2017-2028)
    Figure 18. United States Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Tinea Corporis Drugs Market Share by Country (2017-2028)
    Figure 22. Germany Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Tinea Corporis Drugs Market Share by Region (2017-2028)
    Figure 30. China Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Tinea Corporis Drugs Market Share by Country (2017-2028)
    Figure 38. Mexico Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Tinea Corporis Drugs Market Share by Country (2017-2028)
    Figure 42. Turkey Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Tinea Corporis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Sun Pharmaceutical Revenue Growth Rate in Tinea Corporis Drugs Business (2017-2022)
    Figure 45. Teva Revenue Growth Rate in Tinea Corporis Drugs Business (2017-2022)
    Figure 46. Glenmark Revenue Growth Rate in Tinea Corporis Drugs Business (2017-2022)
    Figure 47. Aurobindo Revenue Growth Rate in Tinea Corporis Drugs Business (2017-2022)
    Figure 48. AvKare Revenue Growth Rate in Tinea Corporis Drugs Business (2017-2022)
    Figure 49. Novartis Revenue Growth Rate in Tinea Corporis Drugs Business (2017-2022)
    Figure 50. Sebela Revenue Growth Rate in Tinea Corporis Drugs Business (2017-2022)
    Figure 51. Bayer Revenue Growth Rate in Tinea Corporis Drugs Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sun Pharmaceutical
Teva
Glenmark
Aurobindo
AvKare
Novartis
Sebela
Bayer
Frequently Asked Questions
Tinea Corporis Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Tinea Corporis Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Tinea Corporis Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pupilometer

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Lymphedema Treatment

Lymphedema Treatment market is segmented by players, region (country), by Type and by Application ... Read More